Results 21 to 30 of about 379,925 (396)
Molecular Pathogenesis and Targeted Therapies in Well-Differentiated Thyroid Carcinoma [PDF]
Endocrinology and Metabolism, 2014 Four proto-oncogenes commonly associated with well-differentiated thyroid carcinoma, rearranged during transfection (RET)/papillary thyroid cancer, BRAF, RAS, and PAX8/peroxisome proliferator activated receptor-γ, may carry diagnostic and prognostic ...
Jung Guk Kim
doaj +1 more source
Frontiers in Oncology, 2022 Hashimoto’s thyroiditis is the most common cause of hypothyroidism in the iodine-sufficient areas of the world. Differentiated thyroid cancer is the most common thyroid cancer subtype, accounting for more than 95% of cases, and it is considered a tumor ...
Federico Cappellacci +6 more
doaj +1 more source
Actions of Thyroid Hormones on Thyroid Cancers
Frontiers in Endocrinology, 2021 L-Thyroxine (T4) is the principal ligand of the thyroid hormone analogue receptor on the extracellular domain of integrin αvβ3. The integrin is overexpressed and activated in cancer cells, rapidly dividing endothelial cells, and platelets.
Shaker A. Mousa +8 more
doaj +1 more source
Russian clinical practice guidelines for diagnosis and treatment of differentiated thyroid cancer
Эндокринная хирургия, 2015 The project of Russian clinical practice guidelines for diagnosis and treatment of differentiated thyroid cancer is dedicated to the management of patients with differentiated thyroid cancer. The guideline modifications 2016 include the following matters:
Dmitriy Germanovich Bel'tsevich +5 more
doaj +1 more source
Frontiers in Oncology, 2021 The dedifferentiation of differentiated thyroid cancer (DTC) is a challenging problem for radioactive iodine (131I) treatment, also known as radioiodine refractory differentiated thyroid cancer (RAIR-DTC). The purpose of this study was to further explore
Shasha Hou +7 more
doaj +1 more source
TERT Promoter Mutations in Papillary Thyroid Microcarcinomas [PDF]
, 2015 Small papillary thyroid carcinomas have contributed to the worldwide increased incidence of differentiated thyroid cancer observed over the past decades.
Bruno, Rocco +18 more
core +1 more source
2017 Russian clinical practice guidelines for differentiated thyroid cancer diagnosis and treatment
Эндокринная хирургия, 2017 The Russian clinical practice guidelines for diagnosis and treatment of differentiated thyroid cancer is dedicated to the management of patients with differentiated thyroid cancer.
Dmitriy G. Beltsevich +14 more
doaj +1 more source
External radiotherapy of thyroid cancer [PDF]
, 2001 Differentiated thyroid cancer comprises papillary, mixed papillary-follicular and follicular adenocarcinomas. They are mostly hormone-sensitive and respond to thyroid-stimulating hormone (TSH) suppression. The standard treatment is total thyroidectomy. I-
Dühmke, Eckhart, Pollinger, B.
core +1 more source
Recent advances in managing differentiated thyroid cancer [PDF]
, 2018 The main clinical challenge in the management of thyroid cancer is to avoid over-treatment and over-diagnosis in patients with lower-risk disease while promptly identifying those patients with more advanced or high-risk disease requiring aggressive ...
Durante, Cosimo +3 more
core +2 more sources
Advancements in the treatment of differentiated thyroid cancer
Therapeutic Advances in Endocrinology and Metabolism, 2021 Derived from follicular epithelial cells, differentiated thyroid cancer (DTC) accounts for the majority of thyroid malignancies. The threefold increase in DTC incidence over the last three decades has been largely attributed to advancements in detection ...
L. Stewart, J. Kuo
semanticscholar +1 more source